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Objectives. We sought to assess the feasibility and accuracy of
myocardial contrast echocardiography (MCE) using standard
imaging approaches for the detection of perfusion defects in
patients who had a myocardial infarction (MI).
Background. Myocardial contrast echocardiography may be
more versatile than perfusion scintigraphy for identifying the
presence and extent of perfusion defects after MI. However, its
reliability in routine practice is unclear.
Methods. Fundamental or harmonic MCE was performed with
continuous or triggered imaging in 203 patients with a previous
MI using bolus doses of a perfluorocarbon-filled contrast agent
(NC100100). All patients underwent single-photon emission com-
puted tomography (SPECT) after the injection of technetium-99m
(Tc-99m) sestamibi at rest. Quantitative and semiquantitative
SPECT, wall motion and digitized echocardiographic data were
interpreted independently. The accuracy of MCE was assessed for
detection of segments and patients with moderate and severe
sestamibi-SPECT defects, as well as for detection of patients with
extensive perfusion defects (>12% of left ventricle).
Results. In segments with diagnostic MCE, the segmental
sensitivity ranged from 14% to 65%, and the specificity varied
from 78% to 95%, depending on the dose of contrast agent. Using
both segment- and patient-based analysis, the greatest accuracy
and proportion of interpretable images were obtained using
harmonic imaging in the triggered mode. For the detection of
extensive defects, the sensitivity varied from 13% to 48%, with
specificity from 63% to 100%. Harmonic imaging remained the
most accurate approach. Time since MI and SPECT defect
location and intensity were all determinants of the MCE response.
The extent of defects on MCE was less than the extent of either
abnormal wall motion or SPECT abnormalities. The combination
of wall motion and MCE assessment gave the best balance of
sensitivity (46% to 55%) and specificity (82% to 83%).
Conclusions. Although MCE is specific, it has limited sensitiv-
ity for detection of moderate or severe perfusion defects, and it
underestimates the extent of SPECT defects. The best results are
obtained by integration with wall motion. More sophisticated
methods of acquisition and interpretation are needed to enhance
the feasibility of this technique in routine practice.
(J Am Coll Cardiol 1998;32:1260–9)
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The evaluation of myocardial perfusion is an important com-
ponent of the risk stratification of patients with ischemic heart
disease. In patients with stable coronary disease, the extent of
perfusion defects correlates with the ejection fraction and is a
strong predictor of adverse outcome (1,2). Stress myocardial
perfusion imaging is a more effective predictor of outcome
than is the anatomic extent of coronary disease, as identified by
coronary angiography (3). In the acute care setting, perfusion
See page 1270
imaging may be used to identify those patients presenting with
chest pain in whom ischemia is the likely etiology (4). Once
myocardial infarction (MI) is identified, infarct vessel patency
may have important implications with respect to the selection
of additional therapy, on the basis of the success or failure of
fibrinolysis (5). There is no currently available alternative for
assessment of the efficacy of fibrinolysis, other than coronary
angiography (6). Although myocardial perfusion scintigraphy
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is a useful prognostic marker in acute coronary syndromes (7)
and is readily available in outpatient practice, the time re-
quired for isotope production, the delay caused by imaging and
the need to transport the patient to a nuclear camera all limit
the feasibility of nuclear imaging in acute care situations.
In this context myocardial contrast echocardiography
(MCE) may offer some important advantages for the assess-
ment of perfusion defects after MI. This technique may be
performed with intravenous injections of second-generation
agents, utilizing echocardiography, which is portable, widely
available and inexpensive. To establish the feasibility and
accuracy of this modality in routine practice, we sought to
compare the findings of MCE with an independent measure of
myocardial perfusion obtained using nuclear perfusion imag-
ing, as well as wall motion analysis.
Methods
Study design. This multicenter study involved acquisition
of MCE and single-photon emission computed tomographic
(SPECT) data at 11 institutions. Routine clinical practice was
mimicked by image acquisition by experienced echocardio-
graphers who had no special expertise in MCE. An indepen-
dent review of the echocardiographic images was performed by
qualitative evaluation of standard gray-scale images by an
echocardiographer with experience but not special expertise in
MCE. Nuclear images were interpreted independently at the
nuclear core laboratory of the Cleveland Clinic Foundation.
The institutional review board at each center approved the
study, and all patients gave written informed consent.
Patient selection. Two hundred three patients (age 60 6 11
years, 35 women and 168 men) with MI within the preceding
year were recruited to undergo rest technetium-99m sestamibi
(MIBI)-SPECT and echocardiography within a 48-h interval.
No patients were studied ,5 days after MI. Patients were also
excluded on the basis of the following criteria: clinically
unstable conditions, childbearing potential, hypersensitivity to
MIBI and pregnancy or lactation.
The clinical characteristics of the patients are summarized
in Table 1. Recent MI (,15 days) was present in 29%, and
most patients (78%) had had a single MI. Of the 311 total
infarctions, the site was identified by electrocardiography as
inferior in 101 (32%) and anterior, septal or apical in 167
(54%); the remainder were lateral or of unknown location.
Coronary angiography was performed in 160 patients, with
.50% stenoses present in the left main coronary artery in 3%,
the left anterior descending coronary artery in 49%, the left
circumflex coronary artery in 28% and the right coronary
artery in 34%. Previous angioplasty or bypass surgery had been
performed in 104 patients, including 56 patients who had one
of these procedures within the 3 months preceding the studies.
MIBI-SPECT protocol. Single-photon emission computed
tomography myocardial perfusion imaging was performed
using standard protocols in all patients (8). Single-photon
emission computed tomography imaging was performed 45 to
60 min after injection of 10 to 20 mCi of MIBI. The images
were processed on site to check for technical adequacy at the
time of the examination, and then sent in digital format to the
core laboratory.
Contrast echocardiography. The contrast agent used for
this study was a perfluorocarbon-filled microbubble of median
diameter 3.4 mm (NC100100; Nycomed Imaging AS, Oslo,
Norway). Patients were randomized into seven groups: pla-
cebo, three incremental doses studied with fundamental imag-
ing and three doses using harmonic imaging. The low, inter-
mediate and high doses with fundamental imaging were 0.03,
0.10 and 0.30 ml particles/kg body weight of NC100100, and
with harmonic imaging they were 0.006, 0.03 and 0.15 ml
particles/kg body weight of NC100100. Each patient received
four injections of the same dose, separated by at least 5 min,
with a 10-ml saline flush to the cannula after each injection.
The images were obtained using standard, commercially
available equipment, with harmonic transducers if indicated.
Transducer frequency was selected to give the best baseline
image, using a medium dynamic range (45 to 55 dB), with
maximal power for intermittent imaging and intermediate
power for continuous imaging. The focus was set at two-thirds
of the depth of the image, and postprocessing was done using
Abbreviations and Acronyms
LV 5 left ventricular
MCE 5 myocardial contrast echocardiography
MIBI 5 Tc-99m sestamibi
MI 5 myocardial infarction
SPECT 5 single-photon emission computed tomography
Table 1. Clinical Characteristics of Patients in Each Randomized Dosage Group
Harmonic Imaging Group Fundamental Imaging Group
Placebo Group
(n 5 28)
Low Dose
(n 5 29)
Intermediate Dose
(n 5 29)
High Dose
(n 5 29)
Low Dose
(n 5 30)
Intermediate Dose
(n 5 29)
High Dose
(n 5 29)
Age (yrs) 60 6 10 61 6 12 60 6 11 59 6 12 60 6 10 58 6 12 64 6 10
Male 86% 72% 83% 77% 90% 93% 79%
Single MI 86% 76% 86% 90% 69% 79% 61%
MI ,15 days 28% 14% 31% 37% 21% 35% 36%
Inferior Q waves 55% 52% 52% 37% 34% 69% 46%
Data are presented as the mean value 6 SD or percentage of patients. MI 5 myocardial infarction.
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the most linear curve. Gain was adjusted to see myocardial
tissue speckle on the baseline images, and time and lateral gain
compensations were adjusted to give the best homogeneous
myocardial brightness on the baseline image. After the first
injection of contrast agent, the images were acquired continu-
ously from apical and, if available, parasternal windows. Unless
this was impossible for technical reasons, each image set
comprised apical four-chamber, apical two-chamber and apical
long-axis images, with parasternal long- and short-axis images
if available. After continuous imaging, systolic triggered imag-
ing was performed in sequential cardiac cycles gated on the T
wave. Separate injections were performed for gated imaging in
the apical four-chamber, apical two-chamber and long-axis
views. The images were recorded on super VHS videotape and
transferred to the core laboratory.
Image interpretation SPECT imaging. Single-photon emis-
sion computed tomography images were reoriented and dis-
played in a homogeneous fashion at the core laboratory.
Particular efforts were made to obtain longitudinal plane
images equivalent to the echocardiographic imaging planes,
and the projection images were reviewed to identify artifacts
caused by patient motion and attenuation.
One observer performed SPECT interpretation for all
patients, and reproducibility was examined by review of a
random selection of 20% of studies by another experienced
observer. Using gray-scale and color-coded images oriented in
the short-axis and vertical and horizontal long-axis dimensions,
qualitative and quantitative interpretations were made for
each of the 16 segments, to correspond with the segmentation
at echocardiography (9). Qualitative analysis was based on
categorization of segments as normal uptake, SPECT defects
or not visualized. Visualized areas with SPECT defects were
then interpreted as being caused by perfusion defect or artifact
or as unknown cause. Single-photon emission computed to-
mography defects were identified if activity was ,80% of the
peak tracer activity in the study (,70% in the inferior wall),
provided these data were not influenced by artifacts. Artifacts
were identified if the observer believed that defects were
attributable to soft-tissue attenuation, usually after review of
transaxial images (10,11). Quantitative interpretation was
based on expression of mean segmental activity as a proportion
of maximal activity.
Echocardiographic images. Videotaped images were digi-
tized using standard equipment (Imagevue; Kodak Health
Imaging, Allendale, New Jersey) into a side-by-side display in
which rest images were expressed in one quadrant and the
other three quadrant were filled by sequential images at
various times after the injection. These time intervals varied
according to the presence and duration of attenuation and
adequacy of myocardial visualization, but usually involved
samples at 15, 30, 45, 60, 90, 120 and 180 s after the injection.
Interpretations were not made .3 min after the injection.
A single observer interpreted MCE, and reproducibility was
analyzed by review of 20% of the studies by a second observer.
Overall gain settings and image quality were scored at baseline
and during continuous and gated acquisition. Segmental inter-
pretations were made for visibility, gain settings, contrast effect
and function.
Myocardial contrast effect was interpreted separately for
continuous and triggered image sets, on the basis of a review of
both the digital images and videotape (9). Visualized segments
were characterized as not opacified, poorly opacified or ade-
quately opacified—the last being identified by opacification of
.50% of the segment (Fig. 1). The reviewer interpreted
whether inadequate opacification was due to reduced perfu-
sion, attenuation or artifact, uncertain cause or failure to
develop a contrast effect. The last entailed failure to develop
myocardial contrast opacification because of administration of
insufficient contrast agent, and was identified if all segments
failed to opacify. When some segments became opacified and
others did not, the observer categorized these areas as showing
perfusion defect, artifact or attenuation. This distinction was
made on the basis of the location, extent and characteristics of
the defect. Artifact was most commonly seen in the lateral or
anterior walls (Fig. 2), and attenuation was identified if more
proximal contrast agent in the wall (Fig. 1) or left ventricular
(LV) cavity shadowed the distal part of the image. Segments
were classified as not seen if the image quality was inadequate
or gain settings were too high or too low to produce visualiza-
tion of that segment, or if the segment was cut off.
The LV function was assessed during a separate reading
from the myocardial contrast evaluation. Each segment was
classified as showing normal function, hypokinesia, akinesia or
dyskinesia (9). In the situations where precontrast images were
Figure 1. Normal myocardial per-
fusion by MCE. The initial noncon-
trast image (A) is of good quality
with fairly uniform gain settings.
After injection of contrast agent
(B), myocardial opacification is
seen in the septum, apex and apical
lateral wall (small arrows), with an
attenuation artifact (large arrow)
in the basal lateral wall. The ac-
companying SPECT image (C)
shows normal perfusion by nuclear
imaging.
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too poor to make this interpretation, we used cardiac cycles
demonstrating LV opacification.
Statistical analysis. Results were analyzed from segmental
and patient perspectives. In the segmental analysis, concor-
dance was recorded between the observers for patients in each
MCE dose and imaging group, as well as for scintigraphic and
wall motion analysis. Segmental sensitivity and specificity were
calculated by comparison of the myocardial contrast or wall
motion results, or a combination, with segmental SPECT
results. Sensitivity was thereby defined as the proportion of
moderate and severe SPECT defects identified by MCE as
perfusion defects. In contrast, specificity was defined by the
proportion of segments with normal SPECT showing normal
myocardial contrast opacification by MCE. The limitation of
the overall analysis is that a significant number of segments
may contribute suboptimal data on the basis of inadequate
gain settings or image quality. These situations compromise
the accuracy of the echocardiographic technique through
mechanisms unrelated to the contrast agent. Thus, subanalyses
were performed after exclusion of segments not visualized or
with technical limitations such as inappropriate gain settings or
inadequate image quality. In each situation the impact of
exclusions on test feasibility was expressed. Because of poten-
tial bias introduced by interactions between segments, this
analysis was repeated using a patient-weighted approach
whereby variables were calculated for each patient and then
averaged for all patients.
A second patient analysis was performed by defining pa-
tients with moderate or severe SPECT defects of more than
moderate size as having disease, and those with no or smaller
defects as having no disease. If one or more echocardiographic
segments showed perfusion defects on MCE, it was identified
as a positive MCE response, and if none was identified, as a
negative response.
Comparisons between groups were obtained using the
chi-square test. Logistic regression models were used to iden-
tify independent correlates of correct results. All statistical
analysis was performed using SAS statistical software (SAS
Software, Cary, North Carolina).
Results
Patient characteristics. The groups randomized to differ-
ent doses of the contrast agent were comparable with respect
to baseline clinical variables (Table 1). Similarly, the groups
were comparable with respect to echocardiographic visibility,
wall motion score and extent and severity of SPECT defects
(Table 2). Among the seven groups, 80% to 89% of the
segments were well visualized at baseline. Gain setting and
quality were considered adequate in 60% to 81% of the
studies, of which 91% to 97% of the segments were character-
ized as well visualized.
Normal wall motion was present in 63% to 70% of the
segments across the dose groups. With respect to the severity
of abnormal motion, 13% to 16% of the segments were
hypokinetic and 15% to 22% were akinetic. The extent of wall
motion abnormalities was most commonly seen in the mild to
moderate range (0 to 6 segments), being 76% in the high dose
group and 79% in the intermediate dose group. The two
observers demonstrated a 79% concordance between their
analyses of segmental wall motion.
Most segments (55% to 65%) demonstrated normal myo-
cardial perfusion by SPECT. A concordance of 95% was
reported between the two observers in the categorization of
perfusion defect severity. Most segments (43% to 68%)
showed mild to moderate perfusion defect extent (less than six
segments) by SPECT. Similarly, the extent of perfusion abnor-
mality by harmonic MCE was one segment or less in 55% to
64% of patients.
Comparison of MCE and SPECT. Definition of optimal
contrast dose and imaging methodology. The concordance be-
tween observers, as well as the sensitivity and specificity of
MCE for identifying SPECT perfusion defects and normal
perfusion using segmental analysis, are summarized in Table 3.
For the evaluation of all segments, a trend can be seen
supporting the use of triggered imaging in the harmonic mode,
and the intermediate and highest doses as demonstrating the
most favorable specificity (50% and 67%, respectively).
The first subanalysis involved exclusion of segments con-
tributing suboptimal data on the basis of inadequate gain
Figure 2. Apparent perfusion de-
fect due to artifact. The noncon-
trast image (A) shows lower levels
of backscatter from the lateral wall,
probably due to interposed lung.
After injection of contrast agent
(B), an apparent defect involves the
basal half of the lateral wall (ar-
rows). The accompanying SPECT
image (C) shows normal myocar-
dial perfusion. This pattern is the
most common source of false pos-
itive findings (i.e. reduced MCE
when there should be normal per-
fusion).
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settings or image quality. After the exclusion of these seg-
ments, the sensitivity and specificity were generally increased
(Table 3). Again, this analysis showed that the most favorable
results were obtained in intermediate and high dose imaging
using the triggered harmonic mode. The second subanalysis
focused on exclusion of segments where a contrast defect was
Table 2. Intensity of Single-Photon Emission Computed Tomographic Perfusion Defects, Wall Motion Abnormalities and Contrast Effects on
Patients in Each Randomized Dosage Group
Harmonic Imaging Group Fundamental Imaging Group
Placebo Group
(%)
Low Dose
(%)
Intermediate Dose
(%)
High Dose
(%)
Low Dose
(%)
Intermediate Dose
(%)
High Dose
(%)
SPECT uptake (n 5 464) (n 5 464) (n 5 464) (n 5 476) (n 5 445) (n 5 464) (n 5 398)
Normal 65 63 60 55 56 57 61
Moderate 19 24 20 23 27 20 22
Severe 16 13 19 21 16 23 17
Average uptake (% maximum) 72 73 70 68 70 68 71
Extent #1 segment 31 14 21 13 17 14 25
Wall motion (n 5 456) (n 5 454) (n 5 464) (n 5 475) (n 5 464) (n 5 463) (n 5 448)
Normal 69 68 70 63 64 70 65
Hypokinesia 16 16 15 16 15 13 14
Akinesia 15 16 15 21 20 17 22
Extent #1 segment 14 10 7 10 3 10 7
Continuous MCE (n 5 140) (n 5 172) (n 5 230) (n 5 118) (n 5 93) (n 5 107) (n 5 28)
Normal 19 24 36 13 13 15 0
Perfusion defect 9 12 11 9 3 3 0
Extent #1 segment 64 64 55 80 89 86 100
Triggered MCE (n 5 176) (n 5 278) (n 5 301) (n 5 126) (n 5 128) (n 5 127) (n 5 25)
Normal 31 51 61 15 21 22 0
Perfusion defect 9 16 11 10 5 3 0
Extent #1 segment 62 58 62 78 81 88 100
MCE 5 myocardial contrast echocardiography; SPECT 5 single-photon emission computed tomography.
Table 3. Comparison of Sensitivity and Specificity of Myocardial Contrast Effect for Prediction of Moderate and Severe Single-Photon
Emission Computed Tomographic Perfusion Defects at Each Dose and With Each Imaging Technique
Harmonic Imaging Group Fundamental Imaging Group
Low Dose
(%)
Intermediate Dose
(%)
High Dose
(%)
Low Dose
(%)
Intermediate Dose
(%)
High Dose
(%)
Continuous MCE
Sensitivity
All (segments with SPECT defects) 16 (n 5 140) 19 (n 5 152) 21 (n 5 168) 18 (n 5 188) 5 (n 5 175) 5 (n 5 188)
Adequate gain/quality 21 13 26 19 7 7
Diagnostic segments 58 38 39 56 36 28
Specificity
All (segments without SPECT defects) 21 (n 5 279) 23 (n 5 273) 35 (n 5 278) 11 (n 5 250) 15 (n 5 232) 15 (n 5 260)
Adequate gain/quality 28 25 39 12 12 14
Diagnostic segments 80 72 87 88 78 82
Observer concordance (segments) 74 (n 5 88) 59 (n 5 96) 71 (n 5 92) 84 (n 5 96) 81 (n 5 96) 82 (n 5 74)
Feasibility* (% segments interpretable) 28 35 47 21 17 18
Triggered MCE
Sensitivity
All (segments with SPECT defects) 9 (n 5 111) 26 (n 5 136) 21 (n 5 137) 19 (n 5 176) 8 (n 5 172) 5 (n 5 180)
Adequate gain/quality 13 22 26 23 12 7
Diagnostic segments 29 25 31 56 34 20
Specificity
All (segments without SPECT defects) 33 (n 5 274) 50 (n 5 250) 67 (n 5 249) 16 (n 5 232) 27 (n 5 222) 23 (n 5 224)
Adequate gain/quality 42 61 77 15 27 23
Diagnostic segments 81 88 93 92 93 91
Observer concordance (segments) 85 (n 5 66) 70 (n 5 60) 65 (n 5 80) 59 (n 5 80) 85 (n 5 96) 67 (n 5 90)
Feasibility* (% segments interpretable) 40 66 72 25 27 25
*Proportion of total segments identified as diagnostic. MCE 5 myocardial contrast echocardiography; SPECT 5 single-photon emission computed tomography.
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visualized, but was deemed by the observer to be due to
attenuation (Fig. 1), artifact (Fig. 2) or absence of contrast
effect. When these negative studies were removed, the number
of interpretable segments (expressed as “feasibility”) decreased
further, but exclusion of these segments increased the speci-
ficity of the test to 93% using the highest dose with triggered
harmonic imaging. The proportion of patients in whom the test
was feasible (i.e., delivered data demonstrating either a perfu-
sion defect or normal perfusion) increased with progressively
increasing dosage, and was higher with triggered than with
continuous imaging. On the basis of these results, Figure 3
compares the sensitivity, specificity and accuracy of different
imaging approaches, combining intermediate and high dose
data. This analysis shows that the most favorable approach was
triggered harmonic imaging.
Table 4 summarizes sensitivity, specificity, reproducibility
and feasibility using the patient-based approach. This repro-
duces the same findings as the segmental approach, with the
optimal feasibility being in the triggered harmonic mode at the
highest dose.
Determinants of MCE with optimal dose and methodology.
On the basis of the aforementioned results, subsequent sub-
analyses focused on harmonic imaging with intermediate and
high doses.
The location of the infarct influenced the results of MCE.
In patients with MI in the anterior territory, the specificity
(79%) of MCE was greater than that in those with MI in the
inferior territory (65%). In a logistic regression model, anterior
MI was associated with true negative responses (p 5 0.03),
whereas inferior MI was not (p 5 0.63). However, the feasi-
bility of the test in anterior (86%, p 5 0.20) and inferior
infarctions (75%, p 5 0.33) was similar, as was the sensitivity
(29% vs. 24%, p 5 0.13 vs. 0.41, respectively). Time after MI
also influenced the accuracy of the technique. Myocardial
contrast echocardiography showed a greater specificity in the
setting of recent (5 to 15 days) rather than older infarcts using
continuous (52% vs. 27%, p , 0.001) or triggered imaging
(82% vs. 66%, p 5 0.02).
The relation between the proportion of abnormal segments
Figure 3. Sensitivity and specificity of intermediate and high dose
myocardial contrast agent injection with continuous and triggered
harmonic imaging for detection of SPECT defects. Accuracy data
reflect segments where interpretation was feasible (proportion of total
shown as feasibility).
Table 4. Patient-Weighted Data Comparing the Sensitivity and Specificity of Myocardial Contrast Effect for Prediction of Moderate and
Severe Single-Photon Emission Computed Tomography Perfusion Defects at Each Dose and With Each Imaging Technique
Harmonic Imaging Group Fundamental Imaging Group
Low Dose
(%)
Intermediate Dose
(%)
High Dose
(%)
Low Dose
(%)
Intermediate Dose
(%)
Low Dose
(%)
Continuous MCE
Sensitivity
All 16 (n 5 21) 13 (n 5 26) 21 (n 5 23) 10 (n 5 26) 6 (n 5 24) 3 (n 5 27)
Adequate gain 20 (n 5 12) 13 (n 5 20) 26 (n 5 20) 13 (n 5 22) 7 (n 5 21) 8 (n 5 22)
Dx segments 65 (n 5 5) 43 (n 5 10) 42 (n 5 15) 39 (n 5 8) 27 (n 5 7) 30 (n 5 6)
Specificity
All 23 (n 5 28) 22 (n 5 28) 37 (n 5 29) 13 (n 5 30) 14 (n 5 27) 15 (n 5 29)
Adequate gain 33 (n 5 20) 22 (n 5 22) 39 (n 5 24) 15 (n 5 27) 14 (n 5 25) 16 (n 5 22)
Dx segments 80 (n 5 13) 78 (n 5 13) 89 (n 5 19) 95 (n 5 8) 83 (n 5 9) 81 (n 5 6)
Reproducibility 70 34 66 61 57 51
Feasibility 27 34 48 20 15 18
Triggered MCE
Sensitivity
All 11 (n 5 18) 20 (n 5 23) 17 (n 5 20) 12 (n 5 23) 11 (n 5 22) 5 (n 5 24)
Adequate gain 17 (n 5 11) 21 (n 5 17) 21 (n 5 15) 17 (n 5 18) 10 (n 5 19) 5 (n 5 21)
Dx segments 39 (n 5 7) 25 (n 5 15) 26 (n 5 13) 46 (n 5 7) 24 (n 5 9) 14 (n 5 8)
Specificity
All 31 (n 5 26) 46 (n 5 26) 62 (n 5 26) 16 (n 5 27) 24 (n 5 25) 23 (n 5 26)
Adequate gain 37 (n 5 20) 62 (n 5 21) 70 (n 5 21) 17 (n 5 22) 26 (n 5 22) 23 (n 5 22)
Dx segments 78 (n 5 16) 88 (n 5 21) 91 (n 5 20) 91 (n 5 7) 94 (n 5 12) 93 (n 5 9)
Reproducibility 80 70 61 45 70 29
Feasibility 38 63 70 24 26 25
Dx 5 diagnostic; MCE 5 myocardial contrast echocardiography.
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and the severity of SPECT perfusion defects is illustrated in
Figure 4, A. With both continuous and triggered imaging,
defects were most commonly associated with severe SPECT
defects (activity ,60% of maximum). Moderate SPECT de-
fects (between 60% and 75% of peak activity) showed an
intermediate frequency of MCE defects, and a low frequency
of MCE perfusion defects occurred in the setting of normal
SPECT activity (i.e., 80% to 100% of peak).
Comparison with regional LV function. Normal SPECT
perfusion was present in 1,883 segments, 80% of which showed
normal regional function. Moderate perfusion defects were
reported in 639 segments, among which function was abnormal
in 36%. However, 394 (70%) of the 563 segments with severe
defects were associated with normal function. The relation
between SPECT defect severity and wall motion is described in
Figure 4, B.
Because some discrepancies between SPECT and MCE
may reflect false positive SPECT defects due to soft-tissue
attenuation (in which case wall motion should be normal), the
correlation between MCE and SPECT was reanalyzed when
SPECT and wall motion were in agreement. This analysis also
compensates for discrepancies between SPECT and MCE due
to malalignment between the two modalities. Table 5 shows
that MCE and SPECT were more concordant in segments
where SPECT and wall motion were in agreement and patient-
weighted data were comparable.
Combination of MCE with LV function data. The simplest
means of combining these data is to use wall motion assess-
ment when the MCE data are nondiagnostic. With continuous
imaging, this increased the sensitivity and specificity of the
intermediate and high dose groups from 20% and 32% to 32%
and 87%, also permitting interpretation of all segments. Sim-
ilarly, the sensitivity and specificity of the intermediate and
high dose groups with triggered imaging increased from 24%
and 69% to 27% and 92%.
Myocardial contrast echocardiography and assessment of
regional LV function were combined using a stepwise ap-
proach, whereby wall motion was analyzed first and if this was
abnormal, no MCE evaluation was made, on the basis of the
relatively high specificity of wall motion abnormalities for
SPECT defects. In contrast, if wall motion was normal, seg-
ments were evaluated for myocardial contrast defects. The
latter were classed as positive for coronary disease, whereas
segments showing normal perfusion were classified as negative.
This analysis of intermediate and high dose harmonic studies
gave a sensitivity and specificity of 55% and 83% for triggered
and 46% and 82% for continuous acquisition, respectively.
Detection of extensive perfusion defects. The results were
analyzed according to the ability of the test to predict a
perfusion defect of significant size in individual patients.
Patients were identified as being positive (scar) by SPECT if
Figure 4. Relation of SPECT perfusion defect severity with probability
of MCE perfusion defect (A) and probability of abnormal wall motion
(B). WMA 5 wall motion abnormality.
Table 5. Correlation of Single-Photon Emission Computed Tomography (SPECT) With Harmonic
Myocardial Contrast Echocardiography in the Triggered Mode, According to the Correlation of
SPECT with Wall Motion Analysis (After Exclusion of Nondiagnostic Studies)
Interpretable
Segments
Disagreement SPECT/WM Agreement SPECT/WM
MCE/SPECT
Concordant
(%)
MCE/SPECT
Discordant
(%)
MCE/SPECT
Concordant
(%)
MCE/SPECT
Discordant
(%)
Segmental Data
Low n 5 109 12 8 56 24
Intermediate n 5 196 11 10 51 28
High n 5 215 6 15 66 13
Patient data
Low n 5 17 13 26 54 7
Intermediate n 5 21 10 24 57 9
High n 5 22 6 13 61 20
MCE 5 myocardial contrast echocardiography; WM 5 wall motion.
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more than two segments were abnormal, on the basis of
prognostic data showing defects of .12% to 15% of the LV as
prognostically important. Patients were identified as being
positive (scar) by MCE if there were one or more segments
with perfusion defects on MCE. The results of this analysis are
recorded in Table 6. For this analysis the most favorable results
were obtained using the intermediate dose with the triggered
harmonic imaging approach.
Discussion
In this study we sought to validate the accuracy and
feasibility of MCE in routine clinical practice. Using standard
imaging approaches and qualitative interpretation, the optimal
imaging methodology involved the use of harmonic imaging in
the triggered mode, with intermediate and high doses of
contrast agent. The feasibility of MCE was ;60%, even using
the most effective imaging approach, owing to exclusion of
technically difficult studies and segments that could not be
interpreted. Segmental analysis with the most favorable meth-
odology (triggered harmonic imaging) gave a specificity and
sensitivity of 93% and 31%, respectively, using the maximal
dose, and 88% and 25%, respectively, using the intermediate
dose. The extent of perfusion defects by MCE was less than the
extent of wall motion abnormalities and SPECT defects—this
being partly influenced by the age of the infarct, its site and the
severity of the SPECT defect. Finally, the most favorable
results were obtained in combination with wall motion analysis,
providing a sensitivity of 55% and a specificity of 83%. The
findings indicate that attempts to apply MCE to routine
practice are likely to be inhibited by the need for training, an
optimized acquisition protocol and more sophisticated image
processing and quantitative evaluation.
Influence of technical considerations on MCE. A number
of technical details relating to both contrast agents and imag-
ing require consideration during MCE (12). The use of ade-
quate power and appropriate gain settings is critical. Excessive
regional backscatter—for example, from scar segments after
MI—may prevent recognition of increased backscatter after
the injection of contrast agent. The use of inadequate power or
gain may preclude recognition of contrast agent, especially at a
low dose and when using fundamental imaging. Even in an
optimized image, the reflection of ultrasound from different
areas of myocardium is frequently heterogeneous (13). Sub-
traction techniques may compensate for variations in the rest
image, permitting more reliable detection of contrast agent
and perhaps enhancing the feasibility of the technique (14).
Nonetheless, even with reanalysis of the data after exclusion of
segments with unsatisfactory gain settings in this study, our
results showed a low sensitivity for detection of SPECT
perfusion defects.
Although gas-filled agents (including the one used in this
study) produce large amounts of reflected ultrasound (15),
optimal concentration of contrast agent remains critical. High
bubble concentrations can provoke attenuation in the far field,
owing to shadowing by the high levels of backscatter imposed
by the bubbles proximal to the transducer (15) within the
ventricular cavity or more proximal myocardium. In contrast,
the density of scan lines in the apex causes more intense
destruction of acoustically labile bubbles (16). Thus, opacifi-
cation of the apex may require a greater concentration of
microbubbles than that which is optimal for opacification of
other segments. Bolus administration of contrast agent opaci-
fies the apex, whereas the remainder of the myocardium may
be shadowed by attenuation. A contrast infusion avoids some
of the problems of attenuation, but low doses may lead to
erroneous interpretation of an apical defect. The dependence
of attenuation on the presence of microbubbles indicates that
is unlikely that these issues can be completely addressed by
subtraction of the rest image.
Standard echocardiographic imaging planes have some
limitations for MCE. Parasternal views are often limited by
attenuation caused by right ventricular contrast, so data are
mostly derived from the apical views. In these views the most
frequent segments identified as nondiagnostic are the lateral
segments (13), which typically have the lowest level of back-
scatter in the rest study (Fig. 2). A number of explanations
have been proposed for this variability, and likely causes
include the presence of overlying lung and differences in
myocardial fiber orientation. In this study the limited feasibility
of myocardial contrast due to artifact may reflect the use of
standard imaging planes; the use of off-axis images may have
more favorably visualized these walls.
Table 6. Subanalysis of Sensitivity, Specificity and Feasibility of
Harmonic Myocardial Contrast Echocardiography for Detection of
Patients With Moderate and Severe Single-Photon Emission
Computed Tomographic Defects
Low Dose
(%)
Intermediate Dose
(%)
High Dose
(%)
Continuous MCE
Sensitivity
All 32 37 34
Adequate gain/quality 38 35 42
Diagnostic segments 92 82 49
Specificity
All 25 20 35
Adequate gain/quality 25 21 38
Diagnostic segments 53 33 53
Feasibility 44 54 82
Triggered MCE
Sensitivity
All 23 49 35
Adequate gain/quality 29 45 39
Diagnostic segments 47 47 41
Specificity
All 34 42 53
Adequate gain/quality 31 54 55
Diagnostic segments 46 59 58
Feasibility 67 93 95
MCE 5 myocardial contrast echocardiography.
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Differences between perfusion scintigraphy and MCE.
This study was formulated on the basis of a comparison of
myocardial contrast activity and scintigraphic perfusion imag-
ing. Although these two techniques are analogous, they have
some important differences. First, the localization of tracer is
different with each technique. The intensity of the myocardial
contrast effect is determined by myocardial blood volume (17),
whereas the scintigraphic technique involves cellular uptake of
a perfusion tracer (in this case MIBI, which is concentrated
within the mitochondria) (18). Thus, whereas the echocardio-
graphic technique examines only the delivery of the contrast
agent to the microvasculature, the nuclear technique also
involves the need for viable muscle cells.
Other sources of variability arise from the different imaging
characteristics of echocardiographic and nuclear techniques.
The spatial resolution of these tests are ;1 mm and ;1 cm,
respectively, causing partial volume effects to have a greater
influence on the nuclear rather than the echocardiographic
technique. Left ventricular wall thinning or failure to thicken in
patients who have had an MI therefore accentuates the
intensity of SPECT defects (19). In stunned myocardial seg-
ments the presence of a wall motion abnormality may engen-
der an apparent perfusion defect even though perfusion has
been restored. Hence, the greatest concordance between
SPECT and MCE in this study was obtained in situations
where SPECT was in agreement with wall motion analysis
(Table 6).
Artifacts may be obtained with either technique, and their
causes differ. With perfusion imaging the most frequent cause
of artifacts is attenuation due to overlying soft tissue (11). With
MCE false positive perfusion defects are most commonly
related to attenuation, inadequate gain and anterior and
lateral wall artifact (13).
Finally, myocardial perfusion scintigraphy has become es-
tablished as a highly sensitive technique for the identification
of myocardial perfusion, with a reasonable correlation between
myocardial blood flow and regional tracer uptake (18). Al-
though similar data using MCE have been gathered from
animal models (20), no such relation has been apparent in this
study. This may reflect the limitations of MCE in the clinical
situation, where chest wall attenuation is an important consid-
eration, as well as in this particular study group, because major
reductions of blood flow were uncommon in these patients.
Nonetheless, comparison of MCE, SPECT and wall motion
findings indicate a better correlation between SPECT and wall
motion data than between SPECT and MCE data. Thus, rather
than SPECT being too sensitive, the MCE methods used in this
study were insensitive for the detection of mild and moderate
perfusion defects.
Previous comparisons of MCE and SPECT have not been
comparable with those in the present study. In 41 patients
imaged after intracoronary injection of sonicated meglumine
(21), 51% had normal perfusion using both techniques, and
85% with perfusion defects using both methods had a history
of previous MI. The overall concordance between MCE and
gated SPECT (78%) exceeded that in this study, reflecting the
more reliable delivery of contrast agent using coronary rather
than venous administration. However, defect size was also
smaller with MCE than with SPECT.
Intravenous MCE and nuclear perfusion imaging have been
compared in two previous studies (14,22) of patients with
known or suspected coronary disease undergoing dipyridamole
stress testing. The presence and location of perfusion defects,
as well as their relation to stress, were comparable with MCE
and nuclear imaging. These studies have a number of impor-
tant differences from the current study. First, this study was
multicentric, and as such reflects the acquisition and interpre-
tation of the technique in the hands of expert echocardiogra-
phy laboratories rather than centers specifically dedicated to
MCE. Second, our study involved comparison of rest images
with rest SPECT in patients who had an MI, which may pose
particular problems—for example, partial volume consider-
ations and reactive hyperemia. In contrast, the use of coronary
vasodilation may favor myocardial contrast opacification.
Third, the analysis in our study involved subjective comparison
of unprocessed two-dimensional echocardiographic images.
The use of extensive postprocessing, including subtraction of
the rest image and color coding (14) or videointensity mea-
surements (22), may enhance the feasibility of the technique.
Study limitations. In addition to the differences of MCE
and myocardial perfusion SPECT, comparison of nuclear and
echocardiographic techniques accounts for some of the vari-
ability seen in this study. The presence of wall motion abnor-
malities in 20% of segments with normal flow probably reflects
the influence of myocardial stunning and subendocardial MI,
which may compromise function more so than perfusion. The
comparison of nuclear and echocardiographic techniques also
presents inherent problems in relation to the coregistration of
the segments. Despite attempts to minimize errors caused by
comparison of different segments by careful orientation of the
longitudinal plane axis on the SPECT images, the finding that
many segments with moderately abnormal perfusion demon-
strated normal function (Fig. 4, B) is partly due to problems of
coregistration. Reanalysis of MCE and SPECT when SPECT
and wall motion were in agreement suggests that some of these
discrepancies were due to SPECT attenuation and image
malalignment.
We sought to separate the functional and MCE compo-
nents of the echocardiogram by examining them at different
times. This separation is difficult, as well as artificial, as MCE
is likely to be used clinically by combination with wall motion
assessment. However, by using wall motion score when the
MCE was nondiagnostic, or allowing the wall motion data to
take precedence when this was abnormal, we could improve
the accuracy of MCE.
Transient response imaging has been shown to reduce
bubble destruction due to ultrasound exposure. At the time of
the design of this study, this technique was performed by
triggering on every T wave to optimize visualization of myo-
cardium. Subsequently it has become apparent that triggering
on every second to fifth cycle further reduces the destruction of
bubbles and may augment the density of the myocardial
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contrast signal (22). Combination of transient response imag-
ing with a contrast infusion may enable quantitation of re-
gional myocardial perfusion. The imaging protocols eventually
used for MCE will probably differ from those used in this
study; triggered or continuous imaging is unlikely to be used
separately, and if bolus injections are performed, they will not
necessarily be separated by at least 5 min.
We elected to use qualitative gray-scale analysis of the
images to mirror routine clinical practice with current equip-
ment. Subtraction of baseline data, color coding and quantifi-
cation of contrast agent might have improved the accuracy and
feasibility of MCE in this study. However, such postprocessing
is not in routine use at present.
Conclusions. The findings of this and other studies indicate
that myocardial contrast opacification may be reliably obtained
using intravenous injection of second-generation contrast
agents in combination with harmonic imaging in the triggered
mode. The results of this study reflect the specificity of the test
using current equipment and visual interpretation. However,
MCE is a complicated technique that requires extensive train-
ing, the definition of optimal administration protocols and
sophisticated methods of interpretation. Although contrast
agents have enhanced the field of MCE, these advances have
led to expectations of clinical applications that seem unlikely to
be fulfilled on the basis of this study. To fulfill the expectations
of MCE as a clinical tool, other developments in image
acquisition and postprocessing will be required.
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